2022 so far…24 Feb 2022 20:43
Well I can’t describe it with expletives as it would rightly be filtered, but if you can imagine a description of four letter words that would accurately encapsulate a summary of this year so far for investors. Especially those of a certain disposition who chose to invest in a loss making biotech on AIM. I for one am still holding and have been averaging down as the shares got cheaper. I do not say this to encourage others to do the same, I am just letting you know that I remain convinced in the company and believe the recent dive in the sp is more down to market forces than anything to do with the company. The only company specific news I can think of is that it would appear to be taking longer than hoped to reach break even. But we must remember the tortuous two years we have been through and the affects this has had on surgery rates and the resulting affect on TRX’s bottom line. We will know more when the full results are published in the next month or so. Until then, and most likely afterwards, I will keep the faith!